The Asia Pacificbioreactors market is expected to reach US$ 994.52 Mn by 2027 from US$ 544.51 Mn in 2019. The market is estimated to grow at a CAGR of 7.9% from 2020 to 2027.
The growth of the marketin this region is primarily attributed to the escalating demand for bioreactors and rising number of market players focusing on expanding their business in different countries, rapidly growing biopharmaceutical and biotechnology industries, and increasing adoption of single-use bioreactors. However, stringent regulatory framework is the major factor hindering the market growth in Asia Pacific. Additionally, technological advancements in bioreactors and rising demand of personalized medicinesare the factors that are likely boost the growth of the bioreactorsmarketin this region during the forecast period.
A bioreactor is equipment or system engineered to provide biologically active environment for the production of various medical and pharmaceutical compounds. The vessel is used to carry out a chemical process, which involves organisms or biochemically active substances derived from such organisms. This process can either be aerobic or anaerobic. Bioreactors are commonly cylindrical in shape, ranging in capacities from liters to cubic meters, and are generally made of stainless steel. Bioreactors provide a controllable environment, in terms of pH, temperature, nutrient supply, and shear stress. These equipment are used in a variety of applications, such as production of biopharmaceuticals and tissue engineering products.
The biopharmaceutical industry is one of the most significant contributors to many economies. With the aging population and rising healthcare standards,the demand for pharmaceutical products has been escalating in Asia Pacific countries. For instance, Autekbio, based in Beijing,is one of the few biopharmaceutical manufacturing organizations fully devoted to contract manufacturing of biologicals. TaiMed Biologics Ibalizumab, the FDA-designated orphan drug, is manufactured by contract pharmaceutical manufacturing WuXi PharmaTech. With the increasing demand for drugs and pharmaceuticals, many companies are opting for advanced bioreactor-related specialized services offered by other pharmaceuticals and biotechnology companies; this enables them to speed up the development process and attain lower production costs. Apart from developed economies, emerging economies such as Brazil, China, and India have shown rapid growth in the research landscape. Factors such as increasing approvals for biologics, growing pipeline of biosimilars, and elevating investments in research activities are prime factors facilitating the growth of the bioreactor industry in this region. Moreover, increasing approvals in gene and cell therapies are favoring the growth of the market. The approved gene therapies are Glybera-used to treat Lipoprotein Lipase Deficiency, and Strimvelis- treating ADA-Severe Combined Immunodeficiency.
The ongoing COVID-19 pandemic has badly affected the transportation infrastructure in Asia Pacific, resulting in disruptions in supply chains and shortage of healthcare facilities in low-income countries. To prevent the spread of disease, restrictive measures have been taken in South Korea, Malaysia, Singapore, the Philippines, and India. The COVID-19 outbreak is expected to have short- and long-term impact on the region,which is potentially projected to have negative impact on growth of the bioreactors market in the region.
In 2019, the mammalian cells segment accounted for the largest share of the Asia Pacificbioreactors market. However, the yeast cells segment is expected to register the highest CAGR during the forecast period. Yeasts are cost-effective, fast-growing, and technically feasible and can be used for high-density cell cultures in bioreactors. Moreover rapid growth rate, easy genetic manipulation, complete genome sequence knowledge, cost-effective growth medium requirements, and post-translational modifications flexibility make yeasts perfect hosts for recombinant protein expression.
A few of the significant secondary sources referred to while preparing the report on the Asia Pacific bioreactors marketreport includethe World Health Organization (WHO) andMedical Research Future Fund (MRFF).
TABLE OF CONTENTS
1. Introduction
1.1 Scope of the Study
1.2 Research Report Guidance
1.3 Market Segmentation
 1.3.1 Asia Pacific Bioreactors Market ? By Cell
 1.3.2 Asia Pacific Bioreactors Market ? By Molecule
 1.3.3 Asia Pacific Bioreactors Market ? By Technology
 1.3.4 Asia Pacific Bioreactors Market? By End User
 1.3.5 Asia Pacific Bioreactors Market ? By Country
2. Asia Pacific Bioreactors Market ? Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Asia Pacific Bioreactors Market ? Market Landscape
4.1 Overview
4.2 PEST Analysis
 4.2.1 Bioreactors Market - Asia Pacific PEST Analysis
4.3 Expert Opinion
5. Asia Pacific Bioreactors Market - Key Market Dynamics
5.1 Key Market Drivers
 5.1.1 Increasing Adoption of Single-Use Bioreactors
 5.1.2 Rapid Growth of Biopharmaceutical and Biotechnology Companies
5.2 Key Market Restraints
 5.2.1 Stringent Regulatory Framework
5.3 Key Market Opportunities
 5.3.1 Rising Demand of Personalized Medicine
5.4 Future Trends
 5.4.1 Robust Technological Advancements in Bioreactors
5.5 Impact Analysis
6. Bioreactors Market ? Asia Pacific Analysis
6.1 Asia Pacific Bioreactors Market Revenue Forecasts and Analysis
7. Asia Pacific Bioreactors Market Analysis And Forecasts To 2027 ? By Cell
7.1 Overview
7.2 Asia Pacific Bioreactors market, By Cell 2019 & 2027 (%)
 7.2.1 Asia Pacific Bioreactors Market Revenue and Forecasts to 2027, By Cell (US$ Mn)
7.3 Mammalian Cells
 7.3.1 Overview
 7.3.2 Asia Pacific Mammalian Cells Market Revenue and Forecast to 2027 (US$ Mn)
7.4 Bacterial Cells
 7.4.1 Overview
 7.4.2 Asia Pacific Bacterial Cells Market Revenue and Forecasts to 2027 (US$ Mn)
7.5 Yeast Cells
 7.5.1 Overview
 7.5.2 Asia Pacific Yeast Cells Market Revenue and Forecasts to 2027 (US$ Mn)
7.6 Others
 7.6.1 Overview
 7.6.2 Asia Pacific Others Market Revenue and Forecasts to 2027 (US$ Mn)
8. Asia Pacific Bioreactors Market Analysis ? By Molecule
8.1 Overview
8.2 Asia Pacific Bioreactors Market, By Molecule 2019-2027 (%)
 8.2.1 Asia Pacific Bioreactors Market Revenue and Forecasts to 2027, By Molecule (US$ Mn)
8.3 Monoclonal Antibodies
 8.3.1 Overview
 8.3.2 Asia Pacific Monoclonal Antibodies Market Revenue and Forecasts to 2027 (US$ Mn)
8.4 Vaccines
 8.4.1 Overview
 8.4.2 Asia Pacific Vaccines Market Revenue and Forecasts to 2027 (US$ Mn)
8.5 Recombinant Proteins
 8.5.1 Overview
 8.5.2 Asia Pacific Recombinant Proteins Market Revenue and Forecasts to 2027 (US$ Mn)
8.6 Stem Cells
 8.6.1 Overview
 8.6.2 Asia Pacific Stem Cells Market Revenue and Forecasts to 2027 (US$ Mn)
8.7 Gene Therapy
 8.7.1 Overview
 8.7.2 Asia Pacific Gene Therapy Market Revenue and Forecasts to 2027 (US$ Mn)
8.8 Others
 8.8.1 Overview
 8.8.2 Asia Pacific Others Market Revenue and Forecasts to 2027 (US$ Mn)
9. Asia Pacific Bioreactors Market Analysis ? By Technology
9.1 Overview
9.2 Asia Pacific Bioreactors Market, By Technology 2019-2027 (%)
 9.2.1 Asia Pacific Bioreactors Market Revenue and Forecasts to 2027, By Technology (US$ Mn)
9.3 Wave-Induced Motion SUB
 9.3.1 Overview
 9.3.2 Asia Pacific Wave-Induced Motion SUB Market Revenue and Forecasts to 2027 (US$ Mn)
9.4 Stirred SUB
 9.4.1 Overview
 9.4.2 Asia Pacific Stirred SUB Market Revenue and Forecasts to 2027 (US$ Mn)
9.5 Single-Use Bubble Column
 9.5.1 Overview
 9.5.2 Asia Pacific Single-Use Bubble Column Market Revenue and Forecasts to 2027 (US$ Mn)
9.6 Other Technologies
 9.6.1 Overview
 9.6.2 Asia Pacific Others Market Revenue and Forecasts to 2027 (US$ Mn)
10. Asia Pacific Bioreactors Market Analysis ? By End-User
10.1 Overview
10.2 Asia Pacific Bioreactors Market, By End-User 2019-2027 (%)
 10.2.1 Asia Pacific Bioreactors Market Revenue and Forecasts to 2027, By End-User (US$ Mn)
10.3 Research and Development Organizations
 10.3.1 Overview
 10.3.2 Asia Pacific Research and Development Organizations Market Revenue and Forecasts to 2027 (US$ Mn)
10.4 Biopharma Manufacturers
 10.4.1 Overview
 10.4.2 Asia Pacific Biopharma Manufacturers Market Revenue and Forecasts to 2027 (US$ Mn)
10.5 Contract Manufacturing Organisations (CMOs)
 10.5.1 Overview
 10.5.2 Asia Pacific Contract Manufacturing Organisations Market Revenue and Forecasts to 2027 (US$ Mn)
11. Bioreactors Market Revenue and Forecasts To 2027 ? Geographical Analysis
11.1 Asia Pacific Bioreactors Market Revenue and Forecasts To 2027
 11.1.1 Overview
 11.1.2 Asia Pacific Bioreactors Market Revenue and Forecasts to 2027 (US$ Mn)
 11.1.3 Asia Pacific Bioreactors Market, by Cell ? Revenue and Forecast to 2027 (USD Million)
 11.1.4 Asia Pacific Bioreactors Market, by Molecule ? Revenue and Forecast to 2027 (USD Million)
 11.1.5 Asia Pacific Bioreactors Market, by Technology ? Revenue and Forecast to 2027 (USD Million)
 11.1.6 Asia Pacific Bioreactors Market, by End User ? Revenue and Forecast to 2027 (USD Million)
 11.1.7 Asia Pacific: Bioreactors Market, by Country, 2018 & 2027 (%)
 11.1.7.1 China: Bioreactors Market- Revenue and Forecasts to 2027 (USD Million)
 11.1.7.1.1 China: Bioreactors Market- Revenue and Forecasts to 2027 (USD Million)
 11.1.7.1.2 China Bioreactors Market, by Cell ? Revenue and Forecast to 2027 (USD Million)
 11.1.7.1.3 China Bioreactors Market, by Molecule ? Revenue and Forecast to 2027 (USD Million)
 11.1.7.1.4 China Bioreactors Market, by Technology ? Revenue and Forecast to 2027 (USD Million)
 11.1.7.1.5 China Bioreactors Market, by End User ? Revenue and Forecast to 2027 (USD Million)
 11.1.7.2 Japan: Bioreactors Market ? Revenue and Forecast to 2027 (USD Million)
 11.1.7.2.1 Japan: Bioreactors Market ? Revenue and Forecast to 2027 (USD Million)
 11.1.7.2.2 Japan Bioreactors Market, by Cell ? Revenue and Forecast to 2027 (USD Million)
 11.1.7.2.3 Japan Bioreactors Market, by Molecule ? Revenue and Forecast to 2027 (USD Million)
 11.1.7.2.4 Japan Bioreactors Market, by Technology ? Revenue and Forecast to 2027 (USD Million)
 11.1.7.2.5 Japan Bioreactors Market, by End User ? Revenue and Forecast to 2027 (USD Million)
 11.1.7.3 India: Bioreactors Market- Revenue and Forecasts to 2027 (USD Million)
 11.1.7.3.1 India: Bioreactors Market- Revenue and Forecasts to 2027 (USD Million)
 11.1.7.3.2 India Bioreactors Market, by Cell ? Revenue and Forecast to 2027 (USD Million)
 11.1.7.3.3 India Bioreactors Market, by Molecule ? Revenue and Forecast to 2027 (USD Million)
 11.1.7.3.4 India Bioreactors Market, by Technology ? Revenue and Forecast to 2027 (USD Million)
 11.1.7.3.5 India Bioreactors Market, by End User ? Revenue and Forecast to 2027 (USD Million)
 11.1.7.4 South Korea Bioreactors Market Revenue and Forecasts to 2027 (US$ Mn)
 11.1.7.4.1 South Korea: Bioreactors Market- Revenue and Forecasts to 2027 (USD Million)
 11.1.7.4.2 South Korea Bioreactors Market, by Cell ? Revenue and Forecast to 2027 (USD Million)
 11.1.7.4.3 South Korea Bioreactors Market, by Molecule ? Revenue and Forecast to 2027 (USD Million)
 11.1.7.4.4 South Korea Bioreactors Market, by Technology ? Revenue and Forecast to 2027 (USD Million)
 11.1.7.4.5 South Korea Bioreactors Market, by End User ? Revenue and Forecast to 2027 (USD Million)
 11.1.7.5 Australia Bioreactors Market Revenue and Forecasts to 2027 (US$ Mn)
 11.1.7.5.1 Australia: Bioreactors Market- Revenue and Forecasts to 2027 (USD Million)
 11.1.7.5.2 Australia Bioreactors Market, by Cell ? Revenue and Forecast to 2027 (USD Million)
 11.1.7.5.3 Australia Bioreactors Market, by Molecule ? Revenue and Forecast to 2027 (USD Million)
 11.1.7.5.4 Australia Bioreactors Market, by Technology ? Revenue and Forecast to 2027 (USD Million)
 11.1.7.5.5 Australia Bioreactors Market, by End User ? Revenue and Forecast to 2027 (USD Million)
12. Impact of COVID-19 Pandemic on Asia Pacific Bioreactors Market
12.1 Asia Pacific: Impact Assessment of COVID-19 Pandemic
13. COMPANY PROFILES
13.1 Thermo Fisher Scientific Inc.
 13.1.1 Key Facts
 13.1.2 Business Description
 13.1.3 Products and Services
 13.1.4 Financial Overview
 13.1.5 SWOT Analysis
 13.1.6 Key Developments
13.2 General Electric Company
 13.2.1 Key Facts
 13.2.2 Business Description
 13.2.3 Products and Services
 13.2.4 Financial Overview
 13.2.5 SWOT Analysis
 13.2.6 Key Developments
13.3 GEA Group
 13.3.1 Key Facts
 13.3.2 Business Description
 13.3.3 Products and Services
 13.3.4 Financial Overview
 13.3.5 SWOT Analysis
 13.3.6 Key Developments
13.4 PBS Biotech, Inc.
 13.4.1 Key Facts
 13.4.2 Business Description
 13.4.3 Products and Services
 13.4.4 Financial Overview
 13.4.5 SWOT Analysis
 13.4.6 Key Developments
13.5 MERCK KGaA
 13.5.1 Key Facts
 13.5.2 Business Description
 13.5.3 Products and Services
 13.5.4 Financial Overview
 13.5.5 SWOT Analysis
 13.5.6 Key Developments
14. Appendix
14.1 About the Insight Partners
14.2 Glossary of Terms
LIST OF TABLES
Table 1. Asia Pacific Bioreactors Market Revenue and Forecasts To 2027, By Cell (US$ Mn)
Table 2. Asia Pacific Bioreactors Market Revenue and Forecasts To 2027, By Molecule (US$ Mn)
Table 3. Asia Pacific Bioreactors Market Revenue and Forecasts To 2027, By Technology (US$ Mn)
Table 4. Asia Pacific Bioreactors Market Revenue and Forecasts To 2027, By End-User (US$ Mn)
Table 5. Asia Pacific Bioreactors Market, By Cell? Revenue And Forecast To 2027 (USD Million)
Table 6. Asia Pacific Bioreactors Market, By Molecule? Revenue And Forecast To 2027 (USD Million)
Table 7. Asia Pacific Bioreactors Market, By Technology? Revenue And Forecast To 2027 (USD Million)
Table 8. Asia Pacific Bioreactors Market, By End User ? Revenue And Forecast To 2027 (USD Million)
Table 9. China Bioreactors Market, By Cell ? Revenue And Forecast To 2027 (USD Million)
Table 10. China Bioreactors Market, By Molecule ? Revenue And Forecast To 2027 (USD Million)
Table 11. China Bioreactors Market, By Technology? Revenue And Forecast To 2027 (USD Million)
Table 12. China Bioreactors Market, By End User ? Revenue And Forecast To 2027 (USD Million)
Table 13. Japan Bioreactors Market, By Cell? Revenue And Forecast To 2027 (USD Million)
Table 14. Japan Bioreactors Market, By Molecule? Revenue And Forecast To 2027 (USD Million)
Table 15. Japan Bioreactors Market, By Technology? Revenue And Forecast To 2027 (USD Million)
Table 16. Japan Bioreactors Market, By End User ? Revenue And Forecast To 2027 (USD Million)
Table 17. India Bioreactors Market, By Cell? Revenue And Forecast To 2027 (USD Million)
Table 18. India Bioreactors Market, By Molecule? Revenue And Forecast To 2027 (USD Million)
Table 19. India Bioreactors Market, By Technology ? Revenue And Forecast To 2027 (USD Million)
Table 20. India Bioreactors Market, By End User ? Revenue And Forecast To 2027 (USD Million)
Table 21. South Korea Bioreactors Market, By Cell ? Revenue And Forecast To 2027 (USD Million)
Table 22. South Korea Bioreactors Market, By Molecule ? Revenue And Forecast To 2027 (USD Million)
Table 23. South Korea Bioreactors Market, By Technology? Revenue And Forecast To 2027 (USD Million)
Table 24. South Korea Bioreactors Market, By End User ? Revenue And Forecast To 2027 (USD Million)
Table 25. Australia Bioreactors Market, By Cell? Revenue And Forecast To 2027 (USD Million)
Table 26. Australia Bioreactors Market, By Molecule? Revenue And Forecast To 2027 (USD Million)
Table 27. Australia Bioreactors Market, By Technology? Revenue And Forecast To 2027 (USD Million)
Table 28. Australia Bioreactors Market, By End User ? Revenue And Forecast To 2027 (USD Million)
Table 29. Glossary of Terms, Bioreactors Market
LIST OF FIGURES
Figure 1. Bioreactors Market Segmentation
Figure 2. Asia Pacific Bioreactors Market Overview
Figure 3. Mammalian Cells Segment Held Largest Share of Cell in Bioreactors Market
Figure 4. Japan is Expected to Show Remarkable Growth During the Forecast Period
Figure 5. Asia Pacific Bioreactors Market - Leading Country Markets (US$ Mn)
Figure 6. Bioreactors Market - Asia Pacific PEST Analysis
Figure 7. Bioreactors Market Impact Analysis of Driver and Restraints
Figure 8. Asia Pacific Bioreactors market ? Revenue Forecasts and Analysis ? 2019- 2027
Figure 9. Asia Pacific Bioreactors market, By Cell 2019 & 2027 (%)
Figure 10. Asia Pacific Mammalian Cells Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 11. Asia Pacific Bacterial Cells Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 12. Asia Pacific Yeast Cells Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 13. Asia Pacific Others Revenue and Forecasts to 2027 (US$ Mn)
Figure 14. Asia Pacific Bioreactors Market, by Molecule 2019 & 2027 (%)
Figure 15. Asia Pacific Monoclonal Antibodies Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 16. Asia Pacific Vaccines Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 17. Asia Pacific Recombinant Proteins Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 18. Asia Pacific Stem Cells Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 19. Asia Pacific Gene Therapy Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 20. Asia Pacific Others Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 21. Asia Pacific Bioreactors Market, by Technology 2019 & 2027 (%)
Figure 22. Asia Pacific Wave-Induced Motion SUB Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 23. Asia Pacific Stirred SUB Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 24. Asia Pacific Single-Use Bubble Column Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 25. Asia Pacific Others Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 26. Asia Pacific Bioreactors Market, by End-User 2019 & 2027 (%)
Figure 27. Asia Pacific Research and Development Organizations Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 28. Asia Pacific Biopharma Manufacturers Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 29. Asia Pacific Contract Manufacturing Organisations Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 30. Asia Pacific: Bioreactors Market, By Key Country ? Revenue (2019) (USD Million)
Figure 31. Asia Pacific Bioreactors Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 32. Asia Pacific: Bioreactors Market, By Country, 2018 & 2027 (%)
Figure 33. China Bioreactors Market Revenue and Forecasts To 2027 (USD Million)
Figure 34. Japan: Bioreactors Market- Revenue And Forecasts To 2027 (USD Million)
Figure 35. India: Bioreactors Market- Revenue And Forecasts To 2027 (USD Million)
Figure 36. South Korea: Bioreactors Market- Revenue And Forecasts To 2027 (USD Million)
Figure 37. Australia: Bioreactors Market- Revenue And Forecasts To 2027 (USD Million)
Figure 38. Impact of Covid-19 Pandemic in Asia-Pacific Country Markets
The List of Companies - Asia Pacific Bioreactors Market
1. Thermo Fisher Scientific Inc.
2. General Electric Company
3. GEA Group
4. PBS Biotech, Inc
5. MERCK KGaA